Randomized, phase II study of the insulin-like growth factor-1 receptor inhibitor IMC-A12, with or without cetuximab, in patients with cetuximab- or panitumumab-refractory metastatic colorectal cancer (Q33391425)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Randomized, phase II study of the insulin-like growth factor-1 receptor inhibitor IMC-A12, with or without cetuximab, in patients with cetuximab- or panitumumab-refractory metastatic colorectal cancer |
scientific article |
Statements
1 reference
Randomized, phase II study of the insulin-like growth factor-1 receptor inhibitor IMC-A12, with or without cetuximab, in patients with cetuximab- or panitumumab-refractory metastatic colorectal cancer (English)
1 reference
Diane Lauren Reidy
1 reference
Efsevia Vakiani
1 reference
Marwan G Fakih
1 reference
Muhammad Wasif Saif
1 reference
Joel Randolph Hecht
1 reference
Noah Goodman-Davis
1 reference
Ellen Hollywood
1 reference
Jonathan Schwartz
1 reference
Kumari Chandrawansa
1 reference
Aruna Dontabhaktuni
1 reference
Hagop Youssoufian
1 reference
David B Solit
1 reference
16 August 2010
1 reference
1 reference
1 reference
Identifiers
1 reference